4015 Stock Overview
Manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 6/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Jamjoom Pharmaceuticals Factory Company Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ر.س151.00 |
| 52 Week High | ر.س158.20 |
| 52 Week Low | ر.س100.20 |
| Beta | 0 |
| 11 Month Change | 3.42% |
| 3 Month Change | 16.15% |
| 1 Year Change | 22.56% |
| 33 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | 93.59% |
Recent News & Updates
Shareholder Returns
| 4015 | SA Pharmaceuticals | SA Market | |
|---|---|---|---|
| 7D | 2.7% | -1.4% | -1.5% |
| 1Y | 22.6% | 4.6% | -8.8% |
Return vs Industry: 4015 exceeded the SA Pharmaceuticals industry which returned 4.6% over the past year.
Return vs Market: 4015 exceeded the SA Market which returned -8.8% over the past year.
Price Volatility
| 4015 volatility | |
|---|---|
| 4015 Average Weekly Movement | 3.7% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 4.3% |
| 10% most volatile stocks in SA Market | 7.3% |
| 10% least volatile stocks in SA Market | 2.6% |
Stable Share Price: 4015 has not had significant price volatility in the past 3 months.
Volatility Over Time: 4015's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1994 | n/a | Tarek Youssef Hosni | www.jamjoompharma.com |
Jamjoom Pharmaceuticals Factory Company manufactures and markets pharmaceutical products in the Kingdom of Saudi Arabia and internationally. The company offers products human medicines, nutraceuticals, antibiotics, general analgesics, medicines for treatment of cough, allergy, asthma, heart diseases, blood pressure, diarrhea, vomiting, ulcer, and acidity, as well as various skin infections, cancer diseases, eye drops and ointments, and cosmeceuticals. Jamjoom Pharmaceuticals Factory Company was founded in 1994 and is based in Jeddah, the Kingdom of Saudi Arabia.
Jamjoom Pharmaceuticals Factory Company Fundamentals Summary
| 4015 fundamental statistics | |
|---|---|
| Market cap | ر.س10.57b |
| Earnings (TTM) | ر.س310.97m |
| Revenue (TTM) | ر.س1.19b |
34.0x
P/E Ratio8.9x
P/S RatioIs 4015 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 4015 income statement (TTM) | |
|---|---|
| Revenue | ر.س1.19b |
| Cost of Revenue | ر.س433.89m |
| Gross Profit | ر.س751.54m |
| Other Expenses | ر.س440.57m |
| Earnings | ر.س310.97m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
Aug 06, 2024
| Earnings per share (EPS) | 4.44 |
| Gross Margin | 63.40% |
| Net Profit Margin | 26.23% |
| Debt/Equity Ratio | 0% |
How did 4015 perform over the long term?
See historical performance and comparison